SCHEMBL4846051

SCHEMBL4846051

C=CCc1cc2c(cc1OCCOCC)OCO2

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
ALDH1A1 P00352 4/20 0.42
LMNA P02545 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP3A4 P08684 4/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.38
IGF1R P08069 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK1 P28482 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849521 0.90 ALDH1A1 (0.43) POLBALDH1A1LMNAL3MBTL1SMN1; SMN2
SCHEMBL4843039 0.86 POLB (0.48) POLBALDH1A1LMNASMN1; SMN2CYP3A4
SCHEMBL14193612 0.81 CYP3A4 (0.44) POLBALDH1A1LMNASMN1; SMN2CYP3A4
SCHEMBL21363675 0.81 CYP3A4 (0.44) POLBALDH1A1SMN1; SMN2CYP3A4MAPT
SCHEMBL4843143 0.81 CYP3A4 (0.54) ALDH1A1SMN1; SMN2CYP3A4CYP1A2TSHR
SCHEMBL30262896 0.78 POLB (0.43) POLBALDH1A1SMN1; SMN2CYP3A4MAPT
SCHEMBL14552371 0.77 POLB (0.61) POLBALDH1A1LMNASMN1; SMN2CYP3A4
SCHEMBL21363678 0.73 CDK4 (0.45) POLBALDH1A1L3MBTL1SMN1; SMN2CYP3A4
SCHEMBL14193623 0.72 CYP3A4 (0.57) ALDH1A1LMNASMN1; SMN2CYP3A4CYP1A2
SCHEMBL21363758 0.72 CYP3A4 (0.63) ALDH1A1L3MBTL1SMN1; SMN2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7354911-B2 1,3-benzodioxol compound and use of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-04-08 US disclosed
US-7354911-B2 1,3-benzodioxol compound and use of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-04-08 US disclosed
US-20070231413-A1 1,3-BENZODIOXOL COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-04 US disclosed
US-20070231413-A1 1,3-BENZODIOXOL COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-04 US disclosed
US-20070231413-A1 1,3-BENZODIOXOL COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070231413-A1 1,3-BENZODIOXOL COMPOUND AND USE OF SAME DDT, BBOX1, PRDX1 POLB 3359/4885ALDH1A1 488/4885LMNA 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.